ORIGINAL RESEARCH
Published on 23 Oct 2025
Anti-convulsant efficacy of long-acting injectable cannabidiol formulation (IVL5005) in the pentylenetetrazol-induced convulsions, with pharmacokinetic characterization
doi 10.3389/fphar.2025.1692123
- 680 views
